Form D · Other
ScanTech Sciences, Inc.
Norcross, GA · CIK 0001817726
Offering snapshot reported Aug 19, 2020 · SEC filing
- Reported sold
- $8.03M Offering amount: $15.8M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Jun 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 19, 2020 | Initial | $8,032,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-373577
Source: Form D, filed Aug 19, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Daigrepont, Jr. | Director |
| Dolan P. Falconer | Director |
| John Goodreds | Director |
| Todd Graves | Director |
| Dwayne House | Director, Executive |
| H. Martin Rice | Executive |
| Jose Antonio Rivero, Jr. | Director |
| Chip Starns | Executive |
| Chris Steinbaugh | Director |
Issuer details
Industry: Other (See others in industry)
Address:
4940 Peachtree Industrial Blvd Suite 340
Norcross, GA, 30071
Norcross, GA, 30071